Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma
Conditions
- Brain and Central Nervous System Tumors
Interventions
- DRUG: irinotecan hydrochloride
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators